Related Experiment Video
Updated: Jan 30, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
TM4SF5-mediated KEAP1 Regulation in Hepatocytes Irrelevant to NRF2 Expression and Activity Promotes Oxidative Stress
Eun-Ae Shin1,2, Haesong Lee1,2, Kyung-Hee Pyo1,2
1Department of Pharmacy, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
Abstract:
Metabolic dysfunction-associated steatohepatitis (MASH)-associated fibrosis involves inflammation accompanied by reactive oxygen species (ROS), in addition to abnormal lipid metabolism and extracellular matrix (ECM) deposition. ROS levels are regulated by the NRF2-KEAP1 pathway. Transmembrane 4 L six family member 5 (TM4SF5) is implicated in metabolic dysfunction-associated steatotic liver disease (MASLD). However, it remains unknown how hepatocyte TM4SF5 modulates abnormal lipid and ROS accumulations during MASLD development. Here we assessed the influence of TM4SF5 on NRF2-KEAP1 pathway utilizing various in vitro and in vivo MASLD models. Our results indicate that hepatocyte TM4SF5 downregulates KEAP1 in physiological states and stabilizes KEAP1 in pathological conditions, without altering NRF2 expression. However, TM4SF5-dependent stabilization of KEAP1 was not observed in Tm4sf5 -/- KO mice. At least the cytosolic TM4SF5 C-terminus could bind to KEAP1 for proteosomal degradation. TM4SF5-driven biphasic KEAP1 regulation was associated with increased CD36 levels in normal livers, whereas in hyperlipidemic states, it contributed to oxidative stress and hepatic inflammation. Genetically engineered mice with altered Tm4sf5 and Nrf2 displayed TM4SF5-induced MASLD phenotypes characterized by elevated Keap1, regardless of Nrf2 expression or activity. These findings were more obvious than for mice with Nrf2 mutation alone. Notably, suppression of Keap1 alone nullified the MASLD-promoting effects of TM4SF5. Taken together, these data demonstrate that TM4SF5 can modulate KEAP1 independently of NRF2, identifying TM4SF5-mediated KEAP1 stabilization as a potential therapeutic target for MASLD.
Insights
Transmembrane 4 L six family member 5 (TM4SF5) influences metabolic dysfunction-associated steatohepatitis (MASH) by regulating KEAP1 stability, independent of NRF2. This TM4SF5-KEAP1 interaction is a potential therapeutic target for MASH.
Area of Science:
- Hepatology
- Molecular Biology
- Biochemistry
Background:
- Metabolic dysfunction-associated steatohepatitis (MASH)-associated fibrosis involves inflammation, oxidative stress from reactive oxygen species (ROS), abnormal lipid metabolism, and extracellular matrix (ECM) deposition.
- The NRF2-KEAP1 pathway is crucial for regulating ROS levels.
- Transmembrane 4 L six family member 5 (TM4SF5) is linked to metabolic dysfunction-associated steatotic liver disease (MASLD), but its role in lipid and ROS accumulation during MASLD is unclear.
Purpose of the Study:
- To investigate how hepatocyte TM4SF5 influences the NRF2-KEAP1 pathway in the context of MASLD.
- To determine the mechanism by which TM4SF5 affects KEAP1 stability and its downstream consequences.
Main Methods:
- Utilized various in vitro and in vivo MASLD models.
- Assessed the interaction between TM4SF5 and KEAP1 using wild-type and knockout mice (Tm4sf5-/-).
- Examined the effects of TM4SF5 and KEAP1 modulation on MASLD phenotypes, including lipid accumulation, oxidative stress, and inflammation.
Main Results:
- Hepatocyte TM4SF5 exhibits biphasic regulation of KEAP1: downregulation in physiological states and stabilization in pathological conditions, without affecting NRF2 levels.
- TM4SF5 binds to KEAP1 via its cytosolic C-terminus, promoting KEAP1 proteasomal degradation.
- TM4SF5-mediated KEAP1 stabilization contributes to increased CD36 levels, oxidative stress, and hepatic inflammation in hyperlipidemic MASLD models.
- Genetic alterations in Tm4sf5 and Nrf2 confirmed TM4SF5-induced MASLD phenotypes characterized by elevated Keap1, independent of Nrf2 activity.
- Suppression of KEAP1 alone reversed the MASLD-promoting effects of TM4SF5.
Conclusions:
- TM4SF5 modulates KEAP1 stability independently of NRF2.
- TM4SF5-mediated KEAP1 stabilization is a key driver of MASLD progression.
- Targeting the TM4SF5-KEAP1 interaction presents a potential therapeutic strategy for MASH and MASLD.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
10:42Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
Published on: May 13, 2016
Related Concept Videos
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Cell Specific Gene Expression
Regulation of Metabolism
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Inflammation
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...